Roche, Epidauros, Correlagen and IntegraGen, Genetic Technologies Limited and Bionomics, and The Institute for Genomic Research | GenomeWeb

Roche Updates Its PCR Offerings as Patent Gradually Slips Away

As the remaining moments of Roche’s PCR patent tick away, the company is trying to keep hold on a piece of the market with the launch of a new “highly sensitive” real-time PCR system.

The LightCycler ST300, which has already begun selling is composed of the company’s LightCycler 1.5, a control computer, a centrifuge, and analysis software, that together “generate results in a speedy manner,” said the company.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.